News

Enhanced Insights with CISCRP's New Interactive Dashboard Tool

Enhanced Insights with CISCRP's New Interactive Dashboard Tool

CISCRP Launches Breakthrough Interactive Data Dashboard

The Center for Information and Study on Clinical Research Participation (CISCRP) has introduced an innovative interactive data dashboard offering clinical research stakeholders tailored access to findings from the 2025 Perceptions & Insights study, which represents the largest global survey of public and patient sentiments toward clinical research.

For the first time, sponsors, clinical research organizations (CROs), investigative sites, patient advocates, and the general public have the power to explore, filter, and download de-identified data from over 12,000 participants around the world. This tool transforms CISCRP's biannual study results from standard reports into actionable insights that champions better protocol design, enhances patient engagement, and optimizes recruitment and retention strategies.

Key Features of the Dashboard

The new dashboard is equipped with numerous features that enhance the user experience:

Custom Filtering

This feature allows users to segment data based on geographical regions, demographics, and specific study attributes, providing flexibility in data exploration.

Downloadable Views

Users can export dashboard data or individual tabs in various formats, including PowerPoint slides, PDFs, or images, facilitating easy sharing and presentation of findings.

Transparency

The dashboard offers clear guidance on interpreting the data and acknowledges any limitations, promoting an informed approach to data utilization.

As Annick de Bruin, Chief Research and Insights Officer, stated, "Data-driven decision-making is essential in clinical research. We are excited to offer a new interactive tool that simplifies the identification of trends and tailoring strategies for clinical development programs and community engagement initiatives."

Why It Matters

This dashboard signifies a pivotal shift in how clinical research stakeholders access and apply patient insights. Moving beyond static reports, users can now interactively examine global data to identify trends related to trust, awareness, and participation motivators.

Sponsors and CROs can leverage these insights filtered by demographics or geography to inform protocol designs and fine-tune recruitment and educational strategies to reach varied populations effectively. Advocacy groups and clinical sites, in turn, benefit by gaining deeper insights into the barriers and motivators affecting participation, thus enhancing their outreach endeavors. Policymakers are also empowered to analyze and monitor trends in public and patient reception towards novel clinical trial innovations, including AI technologies and remote trial methods, ultimately aiding in policy formulation.

Making these comprehensive findings freely available empowers the entire clinical research ecosystem to make informed, patient-centered decisions.

Key Findings from the 2025 Study

Some of the notable findings from this insightful study include:

  • Altruism Drives Participation: The desire to help others remains a vital reason for individuals to engage in clinical research.
  • Social Media Matters: Platforms for digital outreach are crucial, with many participants noting they discovered trials through social media.
  • Trust Remains a Challenge: Pharmaceutical companies' public confidence levels remain lower than other stakeholders, emphasizing the need for enhanced transparency and outreach.
  • AI Awareness Grows: Respondents show comfort with AI uses but stress the importance of being transparent about its applications.

Access the Dashboard

Discover the interactive data dashboard and explore its insights for yourself by visiting the official CISCRP website today.

About CISCRP

CISCRP is a worldwide nonprofit organization dedicated to enlightening the public, assisting sponsors in clinical trial transparency, and engaging patients as partners throughout the research framework. With services like plain language summaries, patient advisory boards, and educational initiatives spanning over 45 countries, CISCRP endeavors to promote trust and enhance health literacy. By implementing community engagement strategies, CISCRP aids stakeholders in recognizing the value of research participation and fosters robust partnerships with patients and communities.

Frequently Asked Questions

What is CISCRP?

The Center for Information and Study on Clinical Research Participation (CISCRP) is a nonprofit organization focused on educating the public and fostering transparency in clinical trials.

What is the purpose of the new dashboard?

The dashboard aims to provide accessible, interactive insights from clinical research studies, enhancing stakeholders’ decision-making processes.

How many respondents participated in the 2025 study?

Over 12,000 respondents contributed to the 2025 Perceptions & Insights study, making it the largest of its kind.

What key insights does the dashboard reveal?

The dashboard highlights trends in altruism, social media's role in recruitment, trust challenges in the pharmaceutical sector, and growing awareness of AI.

Who can benefit from this dashboard?

Clinical research stakeholders including sponsors, CROs, patient advocates, and policymakers can all benefit from the insights provided by the dashboard.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 4

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 2

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 2

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 2

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 0

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 3

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 0

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 3

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading

Top 5 Most Recently Viewed Articles

Mirion Technologies Earnings Insights: Key Metrics and Analysis

Updated Category News Views 196

Mirion Technologies Earnings Insights Ahead of Quarterly Release Mirion Technologies (NYSE: MIR) is preparing for an upcoming quarterly earnings announcement that has generated considerable attention among investors. The anticipation is palpable as analysts suggest that the company is poised to report an earnings per share (EPS) of $0.09. Understanding the implications of...

Continue Reading
Algebrik AI Unveils Innovative Advisory Board for Lending Solutions

Updated Category News Views 239

Algebrik AI Unveils New Advisory Board for Future Lending Algebrik AI Inc., a pioneering company in cloud-native and AI-powered loan origination, has announced the establishment of its inaugural Advisory Board. This dynamic group consists of influential leaders from credit unions, dedicated to guiding Algebrik AI as it seeks to redefine the lending sector through...

Continue Reading
Fed Set to Lower Rates: What this Means for the Economy

Updated Category News Views 338

Anticipating Changes from the Federal Reserve As the Federal Reserve's meeting approaches, there's a strong feeling that the Fed will cut interest rates for the first time in over four years. This action comes as the Fed looks to ease the tight economic conditions that were previously put in place to tackle high inflation. The big question now is whether they will choose...

Continue Reading
Investors Urged to Join Visa Inc. Class Action Lawsuit Now

Updated Category News Views 88

Join the Class Action Against Visa Inc. Today Investors who have suffered significant losses related to Visa Inc. (NYSE: V) should consider contacting Robbins LLP for legal guidance. A recent class action has been initiated on behalf of all individuals and entities who purchased or acquired Visa securities during a specific timeframe. This large-scale lawsuit illustrates...

Continue Reading
Freight Technologies Partners with Salzillo for Enhanced TMS Solutions

Updated Category News Views 82

Freight Technologies and Salzillo Collaborate for Improved Logistics Freight Technologies, Inc. (NASDAQ: FRGT), affectionately known as "Fr8Tech," is making remarkable strides in the logistics sector by forming a strategic alliance with Salzillo, a well-respected name in freight transportation. This partnership aims to license Fr8Tech's Fleet Rocket Transportation...

Continue Reading